Why the study?
It was unclear whether blood atherogenic risk increases immediately after statin discontinuation or if a lingering protective legacy effect prevents lipid increases.
Does statin discontinuation rapidly increase blood atherogenic risk in dyslipidemic adults?
Does statin discontinuation rapidly increase blood atherogenic risk in dyslipidemic adults?
Answers are grounded in this paper and cite their sources.
Statin discontinuation leads to a rapid loss of lipid-lowering benefits within 4 days, highlighting the absence of a legacy protective effect.
BACKGROUND AND AIMS: Half of dyslipidemic patients sometimes discontinue statin medication. It is unclear if blood atherogenic risk increases right after statin discontinuation or if there is a lingering protective effect. We sought to determine if a legacy effect prevented blood lipid increases during the first stages of statin cessation. METHODS AND RESULTS: ; P = 0.782), returned to basal levels. CONCLUSIONS: Our data does not support a statin lingering/legacy effect in blood lipids since they dangerously increased after only 4 days of statin withdrawal in every patient, regardless of dose and years under treatment. Reloading statins restored blood lipids, evidencing a reproducible biological effect at the whole-body level.
No takes yet. Share an insight, caveat, or question.
Álvarez-Jiménez et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: